These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 32368615)
1. Ectopic Expression of miR-532-3p Suppresses Bone Metastasis of Prostate Cancer Cells via Inactivating NF-κB Signaling. Wa Q; Zou C; Lin Z; Huang S; Peng X; Yang C; Ren D; Xu D; Guo Y; Liao Z; Wang B; Hu H; Huang S; He P Mol Ther Oncolytics; 2020 Jun; 17():267-277. PubMed ID: 32368615 [TBL] [Abstract][Full Text] [Related]
2. Downregulation of miR-141-3p promotes bone metastasis via activating NF-κB signaling in prostate cancer. Huang S; Wa Q; Pan J; Peng X; Ren D; Huang Y; Chen X; Tang Y J Exp Clin Cancer Res; 2017 Dec; 36(1):173. PubMed ID: 29202848 [TBL] [Abstract][Full Text] [Related]
3. Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway. Ren D; Yang Q; Dai Y; Guo W; Du H; Song L; Peng X Mol Cancer; 2017 Jul; 16(1):117. PubMed ID: 28693582 [TBL] [Abstract][Full Text] [Related]
4. miR-204-5p Represses Bone Metastasis via Inactivating NF-κB Signaling in Prostate Cancer. Wa Q; Huang S; Pan J; Tang Y; He S; Fu X; Peng X; Chen X; Yang C; Ren D; Huang Y; Liao Z; Huang S; Zou C Mol Ther Nucleic Acids; 2019 Dec; 18():567-579. PubMed ID: 31678733 [TBL] [Abstract][Full Text] [Related]
5. miR-582-3p and miR-582-5p Suppress Prostate Cancer Metastasis to Bone by Repressing TGF-β Signaling. Huang S; Zou C; Tang Y; Wa Q; Peng X; Chen X; Yang C; Ren D; Huang Y; Liao Z; Huang S; Zou X; Pan J Mol Ther Nucleic Acids; 2019 Jun; 16():91-104. PubMed ID: 30852380 [TBL] [Abstract][Full Text] [Related]
6. Downregulation of miR-133a-3p promotes prostate cancer bone metastasis via activating PI3K/AKT signaling. Tang Y; Pan J; Huang S; Peng X; Zou X; Luo Y; Ren D; Zhang X; Li R; He P; Wa Q J Exp Clin Cancer Res; 2018 Jul; 37(1):160. PubMed ID: 30021600 [TBL] [Abstract][Full Text] [Related]
7. Decreased miR-218-5p Levels as a Serum Biomarker in Bone Metastasis of Prostate Cancer. Peng P; Chen T; Wang Q; Zhang Y; Zheng F; Huang S; Tang Y; Yang C; Ding W; Ren D; Huang Z; Guo Y Oncol Res Treat; 2019; 42(4):165-185. PubMed ID: 30870834 [TBL] [Abstract][Full Text] [Related]
8. Transcriptional downregulation of miR-133b by REST promotes prostate cancer metastasis to bone via activating TGF-β signaling. Huang S; Wa Q; Pan J; Peng X; Ren D; Li Q; Dai Y; Yang Q; Huang Y; Zhang X; Zhou W; Yuan D; Cao J; Li Y; He P; Tang Y Cell Death Dis; 2018 Jul; 9(7):779. PubMed ID: 30006541 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-23b-3p promotes pancreatic cancer cell tumorigenesis and metastasis via the JAK/PI3K and Akt/NF-κB signaling pathways. Zhang Y; Chen D; Zhang G; Wu X; Zhou L; Lin Y; Ding J; An F; Zhan Q Oncol Lett; 2020 Nov; 20(5):160. PubMed ID: 32934728 [TBL] [Abstract][Full Text] [Related]
10. Altered expression of microRNA-92b-3p predicts survival outcomes of patients with prostate cancer and functions as an oncogene in tumor progression. Wang G; Cheng B; Jia R; Tan B; Liu W Oncol Lett; 2021 Jan; 21(1):4. PubMed ID: 33240410 [TBL] [Abstract][Full Text] [Related]
11. miR-331-3p and Aurora Kinase inhibitor II co-treatment suppresses prostate cancer tumorigenesis and progression. Epis MR; Giles KM; Beveridge DJ; Richardson KL; Candy PA; Stuart LM; Bentel J; Cohen RJ; Leedman PJ Oncotarget; 2017 Aug; 8(33):55116-55134. PubMed ID: 28903407 [TBL] [Abstract][Full Text] [Related]
12. Loss of miR-516a-3p mediates upregulation of ABCC5 in prostate cancer and drives its progression. Zhang H; Lian Z; Sun G; Liu R; Xu Y Onco Targets Ther; 2018; 11():3853-3867. PubMed ID: 30013366 [TBL] [Abstract][Full Text] [Related]
13. The TGF-β signalling negative regulator PICK1 represses prostate cancer metastasis to bone. Dai Y; Ren D; Yang Q; Cui Y; Guo W; Lai Y; Du H; Lin C; Li J; Song L; Peng X Br J Cancer; 2017 Aug; 117(5):685-694. PubMed ID: 28697177 [TBL] [Abstract][Full Text] [Related]
14. EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-κB and Erk1/2 pathways. Lin C; Zong J; Lin W; Wang M; Xu Y; Zhou R; Lin S; Guo Q; Chen H; Ye Y; Zhang B; Pan J J Exp Clin Cancer Res; 2018 Nov; 37(1):283. PubMed ID: 30477559 [TBL] [Abstract][Full Text] [Related]
15. Exosomal miR-141-3p regulates osteoblast activity to promote the osteoblastic metastasis of prostate cancer. Ye Y; Li SL; Ma YY; Diao YJ; Yang L; Su MQ; Li Z; Ji Y; Wang J; Lei L; Fan WX; Li LX; Xu Y; Hao XK Oncotarget; 2017 Nov; 8(55):94834-94849. PubMed ID: 29212270 [TBL] [Abstract][Full Text] [Related]
16. miR-15a-3p Suppresses Prostate Cancer Cell Proliferation and Invasion by Targeting SLC39A7 Via Downregulating Wnt/β-Catenin Signaling Pathway. Cui Y; Yang Y; Ren L; Yang J; Wang B; Xing T; Chen H; Chen M Cancer Biother Radiopharm; 2019 Sep; 34(7):472-479. PubMed ID: 31135177 [No Abstract] [Full Text] [Related]
17. Transcriptional downregulation of miR-127-3p by CTCF promotes prostate cancer bone metastasis by targeting PSMB5. Fan J; Du W; Zhang H; Wang Y; Li K; Meng Y; Wang J FEBS Lett; 2020 Feb; 594(3):466-476. PubMed ID: 31562641 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-17-3p promotes keratinocyte cells growth and metastasis via targeting MYOT and regulating Notch1/NF-κB pathways. Yan H; Song K; Zhang G Pharmazie; 2017 Sep; 72(9):543-549. PubMed ID: 29441982 [TBL] [Abstract][Full Text] [Related]
19. MiR-199a-3p suppresses proliferation and invasion of prostate cancer cells by targeting Smad1. Qu F; Zheng J; Gan W; Lian H; He H; Li W; Yuan T; Yang Y; Li X; Ji C; Yan X; Xu L; Guo H Oncotarget; 2017 Aug; 8(32):52465-52473. PubMed ID: 28881744 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3. Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]